Baxitozine
Alternative Names: RU 38086Latest Information Update: 30 Aug 1994
At a glance
- Originator Aventis
- Developer Roussel-Maestretti
- Class Antisecretories; Cytoprotectives; Small molecules
- Mechanism of Action Histamine H2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gastric ulcer; Peptic ulcer
Most Recent Events
- 30 Aug 1994 Discontinued-II for Gastric ulcer in France (PO)
- 30 Aug 1994 Discontinued-II for Gastric ulcer in Italy (PO)